TrialBlood advances2020

Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features.

Xian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.